![Momenta Pharmaceuticals logo](/news-release/logo/330730/0/330730.jpg?lastModified=12%2F09%2F2016%2022%3A36%3A50&size=2)
Momenta Pharmaceuticals Announces Date of Earnings Release and Conference Call for Fourth Quarter and Year End 2011 Financial Results
01 févr. 2012 08h30 HE
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Feb. 1, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will...
![Momenta Pharmaceuticals logo](/news-release/logo/330730/0/330730.jpg?lastModified=12%2F09%2F2016%2022%3A36%3A50&size=2)
Momenta Pharmaceuticals Motion for Preliminary Injunction Against Amphastar Pharmaceuticals, Inc., Watson Pharmaceuticals, Inc. and International Medical Systems, Ltd. Stayed
26 janv. 2012 13h15 HE
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Jan. 26, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
![Momenta Pharmaceuticals logo](/news-release/logo/330730/0/330730.jpg?lastModified=12%2F09%2F2016%2022%3A36%3A50&size=2)
Momenta to Host Investor Conference Call on December 23, 2011 to Discuss Follow-On Biologics Collaboration With Baxter
22 déc. 2011 16h19 HE
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Dec. 22, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
![Momenta Pharmaceuticals logo](/news-release/logo/330730/0/330730.jpg?lastModified=12%2F09%2F2016%2022%3A36%3A50&size=2)
Momenta Pharmaceuticals Acquires Assets From Virdante Pharmaceuticals
05 déc. 2011 08h00 HE
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Dec. 5, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
![Momenta Pharmaceuticals logo](/news-release/logo/330730/0/330730.jpg?lastModified=12%2F09%2F2016%2022%3A36%3A50&size=2)
TIME CHANGE: Momenta Pharmaceuticals to Present at the 2011 Deutsche Bank BioFEST
01 déc. 2011 14h15 HE
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Dec. 1, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
![Momenta Pharmaceuticals logo](/news-release/logo/330730/0/330730.jpg?lastModified=12%2F09%2F2016%2022%3A36%3A50&size=2)
Momenta Pharmaceuticals to Present at the 2011 Deutsche Bank BioFEST
28 nov. 2011 17h00 HE
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Nov. 28, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
![Momenta Pharmaceuticals logo](/news-release/logo/330730/0/330730.jpg?lastModified=12%2F09%2F2016%2022%3A36%3A50&size=2)
Momenta Pharmaceuticals Reports $1.18 Earnings per Share for the Third Quarter of 2011
07 nov. 2011 08h51 HE
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Nov. 7, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
![Momenta Pharmaceuticals logo](/news-release/logo/330730/0/330730.jpg?lastModified=12%2F09%2F2016%2022%3A36%3A50&size=2)
Momenta Pharmaceuticals Obtains Preliminary Injunction Against Amphastar Pharmaceuticals, Inc., Watson Pharmaceuticals, Inc. and International Medical Systems, Ltd.
28 oct. 2011 16h47 HE
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Oct. 28, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
![Momenta Pharmaceuticals logo](/news-release/logo/330730/0/330730.jpg?lastModified=12%2F09%2F2016%2022%3A36%3A50&size=2)
Momenta Pharmaceuticals Announces That Launch of Authorized Generic Lovenox(R) Triggers Change in Collaboration Terms
24 oct. 2011 17h13 HE
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Oct. 24, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
![Momenta Pharmaceuticals logo](/news-release/logo/330730/0/330730.jpg?lastModified=12%2F09%2F2016%2022%3A36%3A50&size=2)
Momenta Pharmaceuticals Announces Date of Earnings Release and Conference Call for Third Quarter 2011 Financial Results
24 oct. 2011 10h45 HE
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Oct. 24, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will...